These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Efficacy of oral telithromycin in community-acquired pneumonia caused by resistant Streptococcus pneumoniae.
    Author: van Rensburg D, Fogarty C, De Salvo MC, Rangaraju M, Nusrat R.
    Journal: J Infect; 2005 Oct; 51(3):201-5. PubMed ID: 16230216.
    Abstract:
    The efficacy of oral telithromycin 800mg once daily for 7 days was evaluated in a multicentre, multinational study in patients with community-acquired pneumonia caused by Streptococcus pneumoniae resistant to penicillin and/or erythromycin. Per-protocol clinical and bacteriological outcomes were assessed 10-17 days post-therapy. Of the 129 patients with S. pneumoniae infection, 16 were infected with strains resistant to penicillin and/or erythromycin. Fifteen of these 16 patients (93.8%) were assessed as clinically and bacteriologically cured at the post-therapy visit.
    [Abstract] [Full Text] [Related] [New Search]